True Wealth Design’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$169K Buy
219
+56
+34% +$42.9K 0.05% 117
2025
Q4
$126K Buy
163
+38
+30% +$25.8K 0.04% 142
2025
Q3
$70.3K Buy
125
+118
+1,686% +$66.7K 0.02% 235
2025
Q2
$3.67K Sell
7
-5
-42% -$2.79K ﹤0.01% 933
2025
Q1
$7.61K Buy
12
+10
+500% +$6.88K ﹤0.01% 550
2024
Q4
$1.43K Sell
2
-1
-33% -$839 ﹤0.01% 823
2024
Q3
$3.15K Hold
3
﹤0.01% 676
2024
Q2
$3.15K Buy
3
+1
+50% +$969 ﹤0.01% 310
2024
Q1
$1.93K Buy
2
+1
+100% +$951 ﹤0.01% 353
2023
Q4
$879 Sell
1
-1
-50% -$823 ﹤0.01% 377
2023
Q3
$1.65K Hold
2
﹤0.01% 282
2023
Q2
$1.44K Hold
2
﹤0.01% 291
2023
Q1
$1.64K Sell
2
-1,127
-100% -$850K ﹤0.01% 347
2022
Q4
$815K Buy
+1,129
New +$833K 0.38% 45

Other funds holding REGN